ANGO vs DHR · rev $292.5M vs P/E 39, rev $24.57B
AngioDynamics Inc (ANGO) versus Danaher Corporation (DHR) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Danaher Corporation (DHR) is a diagnostics & research company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported DHR revenue for 2025-12-31 was $24.57B. Net income was $3.61B. Revenue was up 2.9% from 2024-12-31 to 2025-12-31. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
ANGO currently screens at market cap $378.5M. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
Not investment advice. Open the ANGO and DHR stock pages for the full models.
Not investment advice.